Numbers of functional bone marrow colony-forming cells decrease late in SIV infection of rhesus monkeys. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Numbers of functional bone marrow colony-forming cells decrease late in SIV infection of rhesus monkeys.

Symp Nonhum Primate Models AIDS. 1990 Nov 28-30;8:38 (abstract no. 22). Unique Identifier : AIDSLINE PRIM8/900022
Beltz LA; Narayan O; Adams RJ; Zink MC; Donnenberg AD; The Johns Hopkins University, School of Medicine, Baltimore, MD


Abstract: We have used a long term bone marrow (BM) culture system to estimate progenitor frequency by limiting dilution analysis (LDA) in 7 Rhesus macaques studied before and after infection with SIV251. BM cells were first separated on a Ficoll/Hypaque gradient, then depleted of T lymphocytes plus early and mature monocyte/macrophages and granulocytes by 2 rounds of antibody-complement mediated lysis (anti-CD2 plus anti-CD15) followed by overnight adherence to plastic. This procedure not only removes cell types reported to harbor SIV, but also enriches for progenitor cells. These cells were diluted in half-log steps and plated in 96-well plates (1000 to 3 cells/well, 60 replicates/dilution) in medium containing 30% FCS, 1% BSA and recombinant human growth factors in combination designed to drive colony growth toward the monocyte lineage (M-CSF plus GM-CSF). LDA, performed weekly from day 7 to 84, revealed that early during SIV infection (11-19 weeks), there was a significant increase in the number of functional progenitors in enriched BM. This was evidenced by 7-fold and 5-fold increases in total colony-forming cells (day 14 colonies) and in primative colony-forming cells (able to sustain longterm growth), respectively. Later in infection (weeks 31-40), the recovery of functional progenitors (early and long-term colony-forming cells) declined, dropping below preinfection values by approximately 42 weeks post infection. This drop occurred at times when no SIV could be detected (by syncytia formation, p27 ELISA, or in situ hybridization before or after coculture with CEM cells) in these lymphocyte/monocyte depleted samples. The monkeys were, however, antibody positive for SIV at all post-infection intervals, and the virus could be detected in whole BM and peripheral blood by coculture with PHA blasts or CEM cells. Interestingly, we have succeeded in isolating SIV from lymphocyte/monocyte depleted long term BM cultures in 5/5 animals evaluated at the latest time points (8-10 months) in this longitudinal study. Detection of virus by p27 ELISA required coculture with CEM cells and correlated with profound depression of stem cell function as measured in our long term assay system.
Keywords: Animal Antibodies, Viral/ANALYSIS *Blood Cell Count Bone Marrow/CYTOLOGY/IMMUNOLOGY/*MICROBIOLOGY Cell Division Cells, Cultured Cytopathogenic Effect, Viral Granulocyte-Macrophage Colony-Stimulating Factor/IMMUNOLOGY Longitudinal Studies Lymphocytes/MICROBIOLOGY Macaca mulatta Macrophage Colony-Stimulating Factor/IMMUNOLOGY Macrophages/MICROBIOLOGY Recombinant Proteins/PHARMACOLOGY Simian Acquired Immunodeficiency Syndrome/*IMMUNOLOGY Stem Cells/IMMUNOLOGY/*MICROBIOLOGY/PHYSIOLOGY SIV/IMMUNOLOGY/ISOLATION & PURIF Virus Cultivation ABSTRACTKWDanimalantibodies,viral/analysisKWDbloodcellcountbonemarrow/cytology/immunology/
910730
M9170972

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .